American Beacon ARK Transformational Innovation Fund R6 Class
ADNRX
NASDAQ
| Weiss Ratings | ADNRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Weak | |||
| Reward Grade | D | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Company Info | ADNRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | American Beacon | |||
| Manager/Tenure (Years) | Catherine D. Wood (9) | |||
| Website | http://www.americanbeaconfunds.com | |||
| Fund Information | ADNRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | American Beacon ARK Transformational Innovation Fund R6 Class | |||
| Category | Technology | |||
| Sub-Category | Technology Sector Equity | |||
| Prospectus Objective | World Stock | |||
| Inception Date | Oct 28, 2020 | |||
| Open/Closed To New Investors | Open | |||
| Minimum Initial Investment | 0.00 | |||
| Minimum Subsequent Investment | 50.00 | |||
| Front End Fee | -- | |||
| Back End Fee | -- | |||
| Dividends and Shares | ADNRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 0.00% | |||
| Dividend | ADNRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | 0.06% | |||
| Asset Allocation | ADNRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | 0.84% | |||
| Stock | 99.16% | |||
| U.S. Stock | 88.73% | |||
| Non-U.S. Stock | 10.43% | |||
| Bond | 0.00% | |||
| U.S. Bond | 0.00% | |||
| Non-U.S. Bond | 0.00% | |||
| Preferred | 0.00% | |||
| Convertible | 0.00% | |||
| Other Net | 0.00% | |||
| Price History | ADNRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 6.61% | |||
| 30-Day Total Return | 7.16% | |||
| 60-Day Total Return | 19.60% | |||
| 90-Day Total Return | 11.78% | |||
| Year to Date Total Return | 18.48% | |||
| 1-Year Total Return | 8.97% | |||
| 2-Year Total Return | 92.71% | |||
| 3-Year Total Return | 121.40% | |||
| 5-Year Total Return | -21.58% | |||
| Price | ADNRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | -- | |||
| 1-Month Low Price | -- | |||
| 1-Month High Price | -- | |||
| 52-Week Low Price | -- | |||
| 52-Week Low Price (Date) | -- | |||
| 52-Week High Price | -- | |||
| 52-Week High Price (Date) | -- | |||
| NAV | ADNRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Nav | $25.13 | |||
| 1-Month Low NAV | $23.41 | |||
| 1-Month High NAV | $25.13 | |||
| 52-Week Low NAV | $17.56 | |||
| 52-Week Low NAV (Date) | Mar 30, 2026 | |||
| 52-Week High NAV | $25.13 | |||
| 52-Week High Price (Date) | Sep 18, 2026 | |||
| Beta / Standard Deviation | ADNRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 2.41 | |||
| Standard Deviation | 40.57 | |||
| Balance Sheet | ADNRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 161.82M | |||
| Operating Ratios | ADNRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 1.05% | |||
| Turnover Ratio | 47.00% | |||
| Performance | ADNRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | 43.69% | |||
| Last Bear Market Total Return | -39.36% | |||